Cargando…
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion
BACKGROUND: Alterations in the extracellular matrix (ECM) can affect host-tumor interactions and tumor growth and metastasis. Tissue transglutaminase (TG2, EC 2.3.2.13), a calcium-dependent enzyme that catalyzes covalent cross-linking of proteins, can render the ECM highly stable and resistant to pr...
Autores principales: | Mangala, Lingegowda S, Arun, Banu, Sahin, Aysegul A, Mehta, Kapil |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224867/ https://www.ncbi.nlm.nih.gov/pubmed/16153302 http://dx.doi.org/10.1186/1476-4598-4-33 |
Ejemplares similares
-
A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis
por: Wang, Z, et al.
Publicado: (2013) -
Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
por: Kumar, Anupam, et al.
Publicado: (2010) -
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011) -
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
por: Agnihotri, Navneet, et al.
Publicado: (2013) -
Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)